Development of Hillchol®, a low-cost inactivated single strain Hikojima oral cholera vaccine.
Sign Up to like & getrecommendations! Published in 2020 at "Vaccine"
DOI: 10.1016/j.vaccine.2020.10.043
Abstract: Cholera remains an important global health problem with up to 4 million cases and 140,000 deaths annually. Oral cholera vaccines (OCVs) are now a cornerstone of the WHOs "Ending Cholera - A Global Roadmap to… read more here.
Keywords: hillchol; oral cholera; low cost; development hillchol ... See more keywords